The aim of the present study was to identify systematically the measurement properties of patient-reported outcome instruments (PROs) that evaluate adherence to inhaled maintenance medication in adults with asthma.
Introduction
Asthma is a chronic respiratory disease that affects 300 million people worldwide [1] . It is associated with a high clinical and economic burden [2] [3] [4] . To optimize symptom control and reduce the risk of future exacerbations, the Global Initiative for Asthma (GINA) report has recommended doctors to prescribe inhaled corticosteroids (ICS), either alone or in combination with long-acting β 2 -agonists (LABAs), as the preferred maintenance therapy in adults with asthma [5] . The use of inhaled maintenance medication is particularly beneficial to individuals diagnosed with asthma because it enhances patients' quality of life and lung function, and reduces symptoms and exacerbations, when compared with a placebo medication [6] .
Despite clear recommendations to use ICS or ICS -LABA combinations, many patients still underuse these pharmacological treatments [7] [8] [9] [10] . As a result, non-adherence to asthma inhaled maintenance medication has been associated with poor asthma control [7, 9] , and increased hospitalizations [7, 10] and healthcare costs [7, 9] .
Based on a stepwise approach to optimize asthma control, the GINA report has suggested that doctors should first assess adherence to medication and then escalate pharmacotherapy in individuals with uncontrolled asthma who are adherent to their prescribed treatment [5] . Hence, it is crucial that healthcare professionals (HCPs) adequately measure adherence to asthma maintenance medication in routine care. In this regard, objective measures of adherence, such as rates of prescription refills and electronic monitoring, have been promoted [11] , although more simple, timely and inexpensive tools, such as patient-reported outcome instruments (PROs), may be more suitable for daily use [12] .
The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) have been developed to help HCPs and researchers select the best available PRO for a certain purpose, such as measuring adherence behaviours or to identify PROs that need further validation [13] . Based on a Delphi survey of 43 epidemiology, statistics, psychology and clinical medicine experts, the COSMIN group has reached international consensus on the definitions of seven measurement properties for PROs [14] . These definitions are presented in Table 1 and fully explained in a book (see de Vet et al. [15] ). In addition, a checklist for assessment of the methodological quality of studies that aim to evaluate the measurement properties of any PRO has been published (see Mokkink et al. [16] and Mokkink et al. [17] ). Criteria for rating the quality of the measurement properties are also available (see Mokkink et al. [16] and Kotecha et al. [18] ).
To the best of our knowledge, no systematic review has yet been conducted to find out the measurement properties of PROs designed to evaluate adherence behaviours in adults with asthma. Given that poor health outcomes have been associated with patient non-adherence to treatment [7, 9, 10] and that HCPs are required to determine whether uncontrolled asthma is due to non-adherence to inhaled maintenance medication or difficult-to-control asthma [5] , we aimed, in the present study, to identify systematically the measurement properties of PROs used for assessing adherence to inhaled maintenance medication in adults with asthma.
Methods

Design
We conducted a systematic review of measurement properties in accordance with the COSMIN methodology [14, 15, 17, 19] .
Search methods to identify studies
We searched for any study that aimed to evaluate the measurement properties of any PRO that was reported but not restricted to be used for measurement of adherence to inhaled maintenance medication in adults with asthma. By 'adherence', we referred to the following adherence behaviours: initiation, implementation and persistence, according the Ascertaining Barriers to Compliance Taxonomy for Medication Adherence [20, 21] .
We searched the following six databases: CINAHL, Embase, Medline, PsycINFO, the Cochrane Library and Web of Science.
With the assistance of an experienced librarian (Scientific Library, Laval University, Quebec City, QC, Canada), we designed two electronic search strategies that denoted: (i) adherence and (ii) asthma. Additionally, we used two published search strategies designed to denote: (i) PROs and (ii) measurement properties (see Terwee et al. [22] and Mokkink et al. [16] ). These four strategies were based on text and thesaurus words. They were enriched using synonyms, related terms, variant spellings and truncated words. For each database, a specific syntax was used. Detailed Correlation coefficient
Cross-cultural validity 'The degree to which the performance of the items on a translated or culturally adapted [PRO] is an adequate reflection of the performance of the items of the original version of the HR-PRO instrument' [14] .
CFA
Criterion validity 'The degree to which the scores of a [PRO] are an adequate reflection of a 'gold standard' [14] Correlation coefficient
Responsiveness domain
Responsiveness 'The ability of a [PRO] to detect change over time in the construct to be measured' [14] . Responsiveness is 'an aspect of validity. In fact, the only difference between validity and responsiveness is that validity refers to the validity of a single score (estimated on the basis of one measurement), and responsiveness refers to the validity of a change score (estimated on the basis of two measurements)' [15] Correlation coefficient
Other property of PROs Generalizability 'Description of the sample in which the measurement properties of the PRO were evaluated' [17] Mean age, distribution of gender, disease characteristics, country, etc. Table S1 (see online for supporting information). We searched the six databases from inception up until March 2017. We ran the first two search strategies in December 2013, as part of a scoping review that aimed to identify all available PROs used to measure initiation of, implementation of and persistence with inhaled maintenance medication in adults with asthma [23] . To include up-todate studies, we launched these four search strategies in March 2017.
Interpretability
Selection of studies
Search results were exported to Thomson Reuters® END-NOTE®, and one reviewer (M.G.) was responsible for identifying and eliminating duplicates. Two reviewers (M.G., N.P.) independently read titles and abstracts for identification of potentially relevant studies. The reviewers then identified the eligible reports, based on the full-text articles.
We included articles that fulfilled the following criteria:
1. Target condition (construct of interest): adherence (initiation, implementation and persistence) to asthma inhaled maintenance medication. Articles that were written in English, French or Spanish were included because at least two members of our team could read each of those languages. Reviewers' disagreements were resolved by consensus.
Data extraction and management
Based on the COSMIN definitions [14, 15] , the reviewers extracted data on seven measurement properties: hypotheses testing, and (c) cross-cultural validity. 6. Criterion validity. 7. Responsiveness -that is: comparison of change in scores in the PRO under study with change in scores in a gold standard instrument or in a comparator instrument.
Data were also gathered on generalizability and interpretability, including: (i) total score distribution; (ii) minimal (clinically) important change; and (iii) mean ± standard deviation (SD) for different normative groups or subgroups.
Reviewers' disagreements were resolved either by consensus or discussion with a third author (J.M.).
Data analysis and synthesis
Using the COSMIN checklist [17, 19] , the two reviewers assessed the methodological quality of each of the included Table 2 Measurement properties assessed, according to the COSMIN definitions [14, 15] studies, which was rated either as excellent, good, fair or poor. The quality of the measurement properties was rated as positive, negative or undetermined, according to the criteria used by Kotecha et al. [18] . Reviewers' disagreements were resolved either by consensus or discussion with a third author (J.M.). We used the COSMIN criteria that were reported by Kotecha et al. [18] to synthesize, for each PRO, the results of methodological and outcome quality assessments and to determine the level of evidence as strong, moderate, limited or unknown. Figure 1 illustrates the flow of information through the different phases of the systematic review. Overall, our electronic searches resulted in 6073 records. Of these, 659 were retrieved for full-text screening. At the end, 15 studies met our inclusion criteria. These studies were published between 1994 and 2017. Fourteen PROs were identified: (i) the Adult Asthma Adherence Questionnaire (AAAQ) [24] ; (ii) the Adherence Questionnaire [25] ; (iii) the Asthma Diary [26] ; (iv) the 20-item Adherence Starts with Knowledge (ASK-20) [27] ; derived from the Self-Reported Medication-Taking Scale [28] (SRMTS, also referred to as the Morisky -Green): (v) the Inhaler Adherence Scale (IAS) [29, 30] ; (vi) the 15-item Medication Adherence Reasons (MAR) Scale) [31] ; (vii) the 20-item or refined MAR scale [32] ; (viii) the Medication Adherence Report Scale for Asthma (MARS-A) [33, 34] ; also derived from the SRMTS [28] : (ix) the Medication Adherence Scale (MAS) [30] ; (x) the Medication Intake Survey-Asthma (MIS-A) [35] ; (xi) the Patterns of Asthma Medication Use Questionnaire (PAMUQ) [36] ; (xii) the Questions of Interest (QIs) [37] ; (xiii) an unnamed PRO [38] ; and (xiv) the Test of the Adherence to Inhalers (TAI) [39] .
Results
Study selection
Measurement properties
cThe measurement properties that were assessed in each study are summarized in Table 2 . The methodological quality of each of the included studies and the quality of each of the measurement properties are presented in Table 3 . The levels of evidence for each measurement properties are shown in Table 4 .
Internal consistency. The internal consistency was assessed, using Cronbach's alphas, in nine studies of either fair or poor methodological quality [24, 25, 27, 29-32, 34, 39] . Methodological quality was lowered because there was no description of how missing items were handled or because no factor analysis was used to check the unidimensionality of the scales. In four studies of fair methodological quality [25, 32, 34, 39 ], Cronbach's alphas were ≥0.70, which denoted a positive rating. These results suggested a limited level of evidence of the internal consistency of the Adherence Questionnaire [25] , the refined MAR scale [32] , the MARS-A [34] and the TAI [39] .
Reliability. The reliability of the MARS-A and the TAI was measured in two studies of fair methodological quality [34, 39] . The intraclass correlation coefficient calculated by Plaza et al. [39] was ≥0.70, which reflected a positive rating. However, the methodological quality of the study suggested only a limited level of evidence of the reliability of the TAI, owing to the lack of description of how missing items were handled.
Measurement error. No study evaluated the measurement error of any of the included PROs.
Content validity. Three studies reported assessment of content validity [32, 36, 37] . Given that there was not enough information available on what was relevant for adherence measurement or on whether the PROs were comprehensive, neither the methodological quality of these studies nor the quality of this measurement property could be rated.
Construct validity: (i) structural validity, (ii) hypotheses testing and (iii) cross-cultural validity. The structural validity of the AAAQ [24] , the Adherence Questionnaire [25] , the MAR scale [31] , the refined MAR scale [32] , the MARS-A [33, 34] and the TAI [39] was reported. In four studies of fair methodological quality [25, 31, 34, 39 ], factor(s) explained at least 50% of the variance, which suggested a limited level of evidence regarding the structural validity of the Adherence Questionnaire [25] , the MAR scale [31] , the MARS-A [34] and the TAI [39] .
Eight studies [24, 25, 27, 29, 30, 32, 34, 35] relied on hypotheses testing to assess the construct validity of their PRO. The methodological quality of five [24, 27, 29, 30, 34] of these eight studies was rated as poor, mainly because the hypotheses tested were not formulated a priori.
The cross-cultural validity of the MARS-A, translated from English into Spanish, was assessed by Cohen et al. [34] . The methodological quality of this study was rated as poor, given that no confirmatory factor analysis was performed.
Criterion validity. Nine studies [24, 26, 31, 32, 34, [36] [37] [38] [39] reported assessing the criterion validity of their PRO. Three studies of fair methodological quality [26, 34, 39] relied on electronic monitoring as gold standards. In these three studies, correlations with electronic monitoring were <0.70, which reflected a negative rating.
Responsiveness. None of the 15 included studies assessed the responsiveness of any of the 14 PROs, as defined by the COSMIN group; none of the included studies compared change in scores in their PRO with change in scores in a gold standard instrument or in a comparator instrument.
Other properties of PROs
Generalizability and interpretability. The characteristics of study populations are presented in Table 5 . Most of the included studies were conducted in North America (n = 9) or Europe (n = 4).
Even though data on the distribution of adherence scores was reported as mean ± SD or n (%) in 12 out of the 15 included studies, no information on minimal (clinically) important change, or means ± SDs for different normative groups or subgroups was found in any of the included studies.
Table 3
Measurement properties and methodological quality study assessments The quality of each measurement property that was assessed was rated as positive, negative or undetermined. We used the outcome quality criteria reported by Kotecha et al. [18] b
We used the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodological quality criteria [17, 19] c Exploratory factor analysis was performed but authors subsequently decided that the five items of the AAAQ were not part of a single factor, as hypothesized [24] Discussion
Summary of findings
In routine care, doctors may have to escalate pharmacotherapy in patients with uncontrolled asthma who are found to be adherent to their treatment [5] . To measure adherence, PROs have been widely used because they are simple, timely and inexpensive tools [12] . In order to help HCPs or researchers to select the best available PRO to assess adherence behaviours, in the present systematic review we synthesized the measurement properties of 14 PROs. Our results suggested that, for each of the PROs, there was a combination of positive, negative and unknown evidence in regard to their reliability and validity, and that none of the studies assessed the responsiveness of any of the available PROs, as the COSMIN group defines it. Accordingly, our results highlighted the need to conduct further validation studies. These results led us to make five observations. First, more than half of the studies included in the present systematic review assessed the internal consistency of their PRO, along with construct or criterion validity. Although there was a limited positive evidence of the internal consistency for some PROs, positive evidence of construct and criterion validity of each of the included PROs remains to be demonstrated. In this regard, future studies should formulate a priori hypotheses and/or use objective measures of adherence as comparator instruments. Further studies should also focus on demonstrating positive evidence of measurement error, especially in view of the fact that this psychometric property has not been evaluated in any of the included studies. [18] b Exploratory factor analysis was performed but authors subsequently decided that the five items of the AAAQ were not part of a single factor, as hypothesized [24] Secondly, in the present systematic review, no study assessed the responsiveness of any of the included PROs, based on the COSMIN definition [14, 15] . Accordingly, there is no evidence that any of these PROs can detect a change in adherence scores over time. Interestingly, in the most recent Cochrane review of randomized controlled trials of interventions to improve adherence with prescribed medication (including but not restricted to asthma), Nieuwlaat et al. [41] reported that even the most efficient interventions did not result in substantial improvements in adherence. They also suggested that many studies might have failed to show between-group differences owing to inaccurate (self-reported) adherence measurements [41] . When evaluating the impact of any intervention, it is crucial that HCPs and researchers alike rely on an instrument that has been shown to be responsive to change [14, 15] . Although many definitions of responsiveness have been proposed, the COSMIN group has stated that the responsiveness of any PRO should be evaluated in a longitudinal study that would aim to compare change in scores in the PRO under study with change Systematic review of PROs in asthma in scores in a gold standard instrument or in a comparator instrument [15] . Based on the COSMIN definition, responsiveness is an aspect of validity [15] . Accordingly, the estimation of a statistically significant change in a PRO scores after the implementation of an intervention could not serve to demonstrate its responsiveness [15] . Therefore, we suggest that the COSMIN group improves its communication and dissemination activities, in order to help researchers to implement the methodology that it promotes. Thirdly, given that studies were conducted in North America, Europe, Japan or New Zealand, the measurement properties of the included PROs can only be generalized to individuals from high-income countries. Thus, additional studies are needed to assess the reliability, validity and responsiveness of PROs used to measure adherence to inhaled maintenance medication in low-and middle-income countries.
Fourthly, our results suggest that no studies provided HCPs and researchers with commonly understood connotations of the PRO scores. Further high-quality validation studies should evaluate the minimal clinically important change in score of PROs and describe the means ± SDs for different normative groups or subgroups.
Finally, our results suggested that there was limited positive as well as limited negative evidence of the reliability of the MARS-A [34] , and also conflicting evidence of the validity of the Adherence Questionnaire [25] and the TAI [39] . In addition, even though our results showed limited positive evidence of the internal consistency of the refined MAR scale [31] , the quality of the content, construct and criterion validity of this PRO could not be determined in the present systematic review, owing to the lack of information available, and, in turn, we were not able to synthesize the evidence in regard to these three measurement properties. Consequently, our results highlighted the need to conduct further highquality studies in accordance with the COSMIN methodology [14, 17, 19] .
Strengths and limitations
Our systematic review delivered some important messages, as it synthesized the measurement properties of 14 PROs found to measure adherence to inhaled maintenance medication in adults with asthma. Based on a study-specific checklist used to rate the quality of systematic reviews of measurement properties [22] , we acknowledged three study strengths. First, our search strategies were comprehensive as we used a published filter for measurement properties and also because we searched six databases. Secondly, two reviewers performed data extraction and quality assessments independently. Thirdly, we synthesized data on measurement properties.
However, despite these strengths, our systematic review had some limitations. First, as in any systematic review, some studies might have been missed, even though we believe, as advocated above, that our search strategies were comprehensive. Secondly, we did not include PROs when they were used solely to elicit barriers to, or beliefs associated with, adherence. Assessment of such constructs could shed light on the reasons why patients do or do not adhere to their prescribed medication and thus be useful for HCPs in routine care. However, these constructs were beyond the target of the present systematic review.
Conclusions
Our results suggested that there was a combination of positive, negative and unknown evidence in regard to the reliability and validity of the available PROs, and that there was no evidence of the responsiveness of any available instrument. At this point, no recommendation regarding the use of a particular PRO in routine care or in research settings can be provided.
Patient adherence has been shown to be suboptimal in adults with asthma and is associated with high socioeconomic burden [7, 9, 10] . To assist HCPs in assessing patient adherence, we recommend that researchers conduct further high-quality studies to evaluate the reliability, validity, responsiveness and interpretability of their PROs, in accordance with the COSMIN [14, 17, 19] . These studies should also be conducted in high-, middle-and low-income countries.
Findings from an updated version of the present systematic review could inform HCPs and researchers on the most appropriate PRO for measurement of adherence behaviours or advocate for the development and validation of a new instrument. As a result, proper assessment of adherence could help HCPs to understand patients' behaviours better, and researchers better to assess the impact of interventions designed to optimize adherence to beneficial treatment, such as the use of inhaled maintenance medication in adults with asthma.
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